南威軟件(603636.SH):控股子公司太極數智擬申請新三板掛牌
格隆匯3月15日丨南威軟件(603636.SH)公佈,2022年3月15日,南威軟件股份有限公司第四屆董事會第十七次會議審議並通過了《關於控股子公司擬申請新三板掛牌的議案》,同意公司控股子公司深圳太極數智技術有限公司(簡稱“太極數智”)擬申請在全國中小企業股份轉讓系統掛牌。
據悉,太極數智致力於城市數據智能前沿技術研究,以“數據運營改變城市未來,人工智能服務美好生活”為使命,業務涵蓋政務大數據治理、智慧發改、企業服務、互聯網+監督監管和智慧終端等五大領域,向社會提供城市智腦、企業營商環境優化、數字經濟分析和行業數據服務等綜合解決方案,全面賦能“數字城市”建設。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.